StonvexLoading…
StonvexStonvexStonvexCore line items from BL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $700.43M | $653.34M | $590.00M | $522.94M |
Operating Income | $25.55M | $18.54M | $14.35M | $-56.20M |
Net Income | $24.52M | $161.17M | $52.83M | $-29.39M |
EPS (Diluted) | $0.39 | $1.45 | $0.81 | $-0.49 |
Total Assets | $1.76B | $1.83B | $2.10B | $1.94B |
Total Liabilities | $1.39B | $1.34B | $1.81B | $1.81B |
Cash & Equivalents | $390.03M | $885.91M | $271.12M | $200.97M |
Free Cash Flow OCF − CapEx | $161.49M | $188.71M | $120.66M | $45.04M |
Shares Outstanding | 59.88M | 62.81M | 61.52M | 60.02M |